A Study to Evaluate the Safety, Tolerability, and Effects on Blood and Urine Markers of Single Ascending Dose of GSK4771261 in Healthy Participants and Participants With Autosomal Dominant Polycystic Kidney Disease

NCT06734234 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

84

Enrollment

INDUSTRY

Sponsor class

Conditions

Kidney Disease

Interventions

DRUG: GSK4771261
DRUG: Placebo matching GSK4771261

Sponsor

GlaxoSmithKline